Breast Cancer Clinical Trials

Showing 4701-4720 of 5,597 trials

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

NCT02649101

Sixty advanced breast cancer patients are planed to enrolled in this clinical trial. Forty patients are enrolled into thalidomide plus chemotherapy group. Twenty patients are enrolled into chemotherapy alone group. There is no restriction on chemotherapy regimen and lines.

Metastatic Breast Cancer

Zhejiang Cancer Hospital60 participantsStarted Oct 2015

Hangzhou, Zhejiang, China

TERMINATEDPhase 2

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

NCT01919229

This is a multi-center, open-label Phase II randomized pre-surgical pharmacodynamics study.

Early Breast Cancer

Novartis Pharmaceuticals14 participantsStarted Oct 2013

Fayetteville, Arkansas, United States • Los Angeles, California, United States • Boston, Massachusetts, United States +4 more locations

COMPLETEDNA

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

NCT00030823

RATIONALE: Vaccines may make the body build an immune response and decrease the recurrence of breast cancer. PURPOSE: Pilot trial to study the effectiveness of vaccine therapy in treating patients who are at high risk for breast cancer recurrence.

Breast Cancer

Memorial Sloan Kettering Cancer Center14 participantsStarted Mar 2001

New York, New York, United States

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Related Searches

Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy

Adaptated Physical Activity in Cancerology

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Safety Study of Modified Vaccinia Virus to Cancer

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer

A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy

Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer

Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)